Poly Medicure Ltd (POLYMED) is currently trading at 1,388.85 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Poly Medicure Limited is a manufacturer and supplier of medical devices, specializing across diverse product verticals such as infusion therapy, oncology, and dialysis. It operates 10 manufacturing facilities, with a presence in India, China, Egypt, and Italy. The company has recently acquired PendraCare Group and Citieffe Group, marking significant expansions in cardiology and orthopedic segments, expected to add annual revenues of Rs. 280 crores. These acquisitions underline its strategic focus on expanding market reach and product offerings. Poly Medicure reported a consolidated revenue growth of 5.7% in Q2 FY26, with notable domestic revenue growth of 16.9%. It maintains healthy operating EBITDA margins amidst ongoing investments and strategic acquisitions. The company is investing in AI and advanced training through the SARATHI program and PACE initiative, enhancing internal efficiencies and strengthening external partnerships with medical leaders. Poly Medicure's commitment to sustainability is evident in its significant solar energy projects, aiming for reduced emissions and cost efficiencies in operations, reflecting their ongoing environmental responsibility initiatives.

Over the past 52 weeks, Poly Medicure Ltd has traded between a low of ₹1,377.40 and a high of ₹2,936.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Poly Medicure Ltd has a market capitalization of approximately 14,077.31. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Poly Medicure Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 39.92 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Poly Medicure Ltd (POLYMED) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 14,077.31 Cr, Poly Medicure Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Poly Medicure Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Poly Medicure Ltd is 39.92. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Poly Medicure Ltd pays dividends with a current dividend yield of 0.25%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Poly Medicure Ltd include sector-specific challenges in the Healthcare industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.